Showing results (1051-1060 of 1,287) with videos related to
Sort By:
Pageof 129
The Journal of Antimicrobial Chemotherapy|January 29, 2008
What is the risk of mortality following diagnosis of multidrug-resistant HIV-1?D Grover, A Copas, H Green, et al.Archives of Disease in Childhood|January 23, 2008
Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase gamma (POLG1)R McFarland, G Hudson, R W Taylor, et al.Gastrointestinal Endoscopy|November 5, 1997
Combined magnification endoscopy with chromoendoscopy in the evaluation of patients with suspected malabsorptionL M Siegel, P D Stevens, C J Lightdale, et al.Nanotechnology|May 7, 2009
Electron transport behavior of individual zinc oxide coated single-walled carbon nanotubesChin-Ching Lin, Bryan T T Chu, Gerard Tobias, et al.BMJ Case Reports|June 21, 2011
Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase γ (POLG1)R McFarland, G Hudson, R W Taylor, et al.Mutation Research|February 19, 1996
Protective effect of deoxyribonucleosides on UV-irradiated human peripheral blood T-lymphocytes: possibilities for the selective killing of either cycling or non-cycling cellsM H Green, A P Waugh, J E Lowe, et al.Journal of Clinical and Experimental Hepatology|March 11, 2015
Hepatitis C virus treatment in the 'real-world': how well do 'real' patients respond?N Deborah Friedman, Joanne H Green, Hanna M Weber, et al.Mutation Research|July 1, 1977
Mutagen screening by a simplified bacterial fluctuation test: use of microsomal preparations and whole liver cells for metabolic activationM H Green, B A Bridges, A M Rogers, et al.International Journal of Cancer|June 25, 1998
Changes in glutathione redox cycling and oxidative stress response in the malignant progression of NB2 lymphoma cellsT E Meyer, H Q Liang, A R Buckley, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2005
A randomized controlled trial of the value of phenotypic testing in addition to genotypic testing for HIV drug resistance: evaluation of resistance assays (ERA) trial investigatorsD T Dunn, H Green, C Loveday, et al.Pageof 129